Skip to main content
. 2016 Sep 18;2016(9):CD006992. doi: 10.1002/14651858.CD006992.pub2

Fargren 2014.

Methods A single‐centre, double‐blind, randomised, placebo‐controlled cross‐over study
Participants Participants with type 2 diabetes, mean age 59 + 6 (SD) years and mean HbA1c 7.7% + 0.8%, treated with exogenous insulin with or without oral antihyperglycaemic agents
Interventions Participants received vildagliptin (50 mg twice a day) or placebo as add‐on to insulin for 4 weeks in random order with a 4‐week washout in between
Outcomes Glucose, glucagon
Notes